People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cirrascale Corp | — | Other Technology | Series A | $13.2M | $55.6M | 2012 |
| GeneTex International Corp | — | Biotechnology | Series A | $4.3M | $155.4M | 2012 |
Paul Chen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Paul Chen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Marc Brown | 1 | 5 |
| David Driggers | 1 | 3 |
| James St. John | 1 | 2 |
| K.Y. Peng | 1 | 1 |
| Horace H. Loh | 1 | 1 |
| Larry Weismann | 1 | 1 |
| Teresa Yang-Feng | 1 | 1 |
| Christopher Witt | 1 | 1 |
| Wen-Kuang Hsu | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.